Alternatives to Editas Medicine
Editas Medicine is a Biotech tool: a clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotech companies to Editas Medicine
- Website
Intellia Therapeutics40BiotechCambridge, United States$310.0MA clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.
- Website
Gene Bio Medical36BiotechTel Aviv, Israel$10.0MDevelops advanced gene editing and cell therapy solutions for rare genetic diseases.
- Website
Emendo Biotherapeutics59HealthcareTel Aviv, Israel$61.0MDeveloping genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology.
- Website
Verve Therapeutics56BiotechnologyCambridge, USA$300.0MDeveloping gene editing therapies to lower cholesterol.
- Website
Immitra Bio48BiotechnologyZürich, Switzerland$2.6MScalable, one-time curative in-vivo gene editing therapies.
- Website
Beam Therapeutics47WorkflowsCambridge, United States$235.0MA biotechnology company developing precision genetic medicines through base editing technology to treat a broad range of diseases.
- Website GEGeneEdit8BiotechNew York, United States
Developing gene editing therapies for rare genetic diseases.
- Website
Arrakis Bio48Life SciencesCambridge, United StatesArrakis Bio is developing novel therapeutics for cancer and other diseases using a proprietary gene editing platform.
- Website
Mammoth Biosciences63BiotechnologyBrisbane, United States$460.0MBiotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.
- Website
VI Therapeutics31Life SciencesCambridge, United StatesVI Therapeutics is developing novel therapies for rare genetic diseases.
- Website
CRISPR Therapeutics64BiotechnologyZug, Switzerland$547.0MBiotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.
- Website
Precision BioSciences57BiotechnologyDurham, USA$357.6MA clinical-stage biotechnology company developing in vivo gene editing therapies.
- Website
Adaptive Biotechnologies69BiotechSeattle, United States$300.0MLeveraging the adaptive immune system to diagnose and treat disease.
- Website
BeiGene65BiotechCambridge, United States$358.0MA global oncology company developing and commercializing innovative cancer treatments.
- Website LELexeo Therapeutics61BiotechNew York City, United States$495.0M
Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.
- Website
Caris Life Sciences59BiotechIrving, United States$700.0MCaris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
- Website
Guardant Health57BiotechRedwood City, United States$900.0MGuardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.
- Website
Amicus Therapeutics57BiotechPhiladelphia, United States$200.0MBiotechnology company focused on developing treatments for rare metabolic diseases.
- Website
Harmony Biosciences Holdings57BiotechPlymouth Meeting, United States$400.5MBiopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.
- Website
Ultragenyx55BiotechNovato, United States$100.0MBiopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.
Showing the 20 closest matches. See the rest on the Editas Medicine profile.